Matches in Nanopublications for { ?s ?p "[in colorectal cancer and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP105571.RAbHt5OWOuQlp8geZqJ4BmfT5VBgaGOCTaZAK_IiHZJT8130_assertion description "[in colorectal cancer and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105571.RAbHt5OWOuQlp8geZqJ4BmfT5VBgaGOCTaZAK_IiHZJT8130_provenance.
- NP106908.RASoJYeL10Hf1CDrAEpHBQyQ79ndHA7YRl4ThCKgL-fxk130_assertion description "[in colorectal cancer and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP106908.RASoJYeL10Hf1CDrAEpHBQyQ79ndHA7YRl4ThCKgL-fxk130_provenance.
- NP105452.RAlKfZ1hCxspBavPkA6oUO8TLs_QOC3C-ECOAlEzSRjEg130_assertion description "[in colorectal cancer and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105452.RAlKfZ1hCxspBavPkA6oUO8TLs_QOC3C-ECOAlEzSRjEg130_provenance.
- NP106558.RAljkWF2mF5oAxz6sPbkhr9zMRN4OXzQ3g0Woxo5fd_QI130_assertion description "[in colorectal cancer and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP106558.RAljkWF2mF5oAxz6sPbkhr9zMRN4OXzQ3g0Woxo5fd_QI130_provenance.
- NP168789.RASAzjBoFPir5sWnwIpw0r1snMnpl8f61fEOPxGT5Ityw130_assertion description "[in colorectal cancer and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP168789.RASAzjBoFPir5sWnwIpw0r1snMnpl8f61fEOPxGT5Ityw130_provenance.
- NP202146.RAdtraeI4gMjQuA2KIW2I2gdtw-tXbnUIKoWRrztdosUQ130_assertion description "[in colorectal cancer and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP202146.RAdtraeI4gMjQuA2KIW2I2gdtw-tXbnUIKoWRrztdosUQ130_provenance.
- NP202147.RAevpCVyBWB3OjvekBgmn0PkLjny2gj0Ln10et__6LuZw130_assertion description "[in colorectal cancer and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP202147.RAevpCVyBWB3OjvekBgmn0PkLjny2gj0Ln10et__6LuZw130_provenance.
- NP202148.RAWRgWf5_a7phqydRcBctVEfF2WzXZPXIo0aI8QSgZ02c130_assertion description "[in colorectal cancer and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP202148.RAWRgWf5_a7phqydRcBctVEfF2WzXZPXIo0aI8QSgZ02c130_provenance.
- NP170124.RAtGdLWeyyVN9al3tu13KnZaTWtqsXTSdrJCqBeg2j-Iw130_assertion description "[in colorectal cancer and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP170124.RAtGdLWeyyVN9al3tu13KnZaTWtqsXTSdrJCqBeg2j-Iw130_provenance.
- NP202149.RA_ZLNSy_99XpZcMWRTj9zWZnM2mVKUsYdn6qpNyMP1nk130_assertion description "[in colorectal cancer and gastric cancer promoter hypermethylation and transcriptional silencing are frequent for GATA-4 and -5 ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP202149.RA_ZLNSy_99XpZcMWRTj9zWZnM2mVKUsYdn6qpNyMP1nk130_provenance.